Kamiya Hiroyuki, Toyota Emiko, Kobayashi Nobuyuki, Kudo Koichiro
Department of Respiratory Medicine, International Medical Center of Japan, 1-21-1, Toyama, Shinjuku-ku, Tokyo 162-8655 Japan.
Kekkaku. 2006 Apr;81(4):351-5.
The infectious disease is one of the most important complications related to the organ transplantation. Patients using immunosuppressive agents often present atypical tuberculosis and the treatment of such case is far more difficult in some cases due to the liver damage and/or the drug interaction. We report a case of pulmonary tuberculosis in a patient of 60-year-old man using tacrolimus after an orthotopic liver transplantation. He had liver transplanted orthotopically for the long-term history of chronic hepatitis B and subsequent liver failure on January 28, 2004. An abnormal shadow was first detected on his chest X-ray film on October, 2004. He was admitted to our hospital after the smear of the gastric juice showed some acid-fast bacilli and tubercle bacilli were confirmed by polymerase chain reaction (PCR). Tuberculin skin test was positive (erythema 10 x 10) and the computed tomography (CT) scan of his chest revealed a nodular opacity with some smaller nodules scattered around in the right upper lobe. We started four anti-tuberculous drugs other than pyrazinamide (PZA) and rifampicin (RFP), which included isoniazid (INH), ethambutol (EB), streptomycin (SM), levofloxacin (LVFX). The liver enzyme was transiently elevated (AST 123 IU/I, ALT 103 IU/I) but improved after desensitization against INH. The blood concentration of tacrolimus preserved between 5 and 7 ng/ml and there was no need to change the dosage.
传染病是器官移植最重要的并发症之一。使用免疫抑制剂的患者常出现非典型肺结核,在某些情况下,由于肝损伤和/或药物相互作用,此类病例的治疗要困难得多。我们报告一例60岁男性原位肝移植术后使用他克莫司的肺结核患者。他因慢性乙型肝炎长期病史及随后的肝衰竭于2004年1月28日接受原位肝移植。2004年10月,他的胸部X线片首次发现异常阴影。胃液涂片显示一些抗酸杆菌,经聚合酶链反应(PCR)确诊为结核杆菌后,他被收入我院。结核菌素皮肤试验呈阳性(红斑10×10),胸部计算机断层扫描(CT)显示右上叶有一个结节状混浊,周围散在一些较小的结节。我们开始使用除吡嗪酰胺(PZA)和利福平(RFP)之外的四种抗结核药物,包括异烟肼(INH)、乙胺丁醇(EB)、链霉素(SM)、左氧氟沙星(LVFX)。肝酶短暂升高(AST 123 IU/I,ALT 103 IU/I),但在对INH脱敏后有所改善。他克莫司血药浓度维持在5至7 ng/ml之间,无需改变剂量。